of the remaining 67 patients , 25 are off treatment ( phase iv ) , 25 are taking only 50 mg cyclophosphamide daily ( phase iii ) , ten are also in remission , but still receiving intermittent high doses of dexamethasone-cyclophosphamide ( phase ii ) , and seven still have active disease ( phase i ) .
C0010583
cyclophosphamide
C0281507
dexamethasone-cyclophosphamide